NODAGA-MAL-exendin-4 was synthesized in a two-phase approach using solid support to prepare maleoyl-derivatized NODAGA followed by Michael addition to cysteine-derivatized exendin-4 in solution. Radiolabeling was performed in buffered aqua with [64Cu]CuCl2, which was produced via the 64Ni(p,n)64Cu nuclear reaction. The in vitro and in vivo stability, lipophilicity, and distribution kinetics in major rat organs for [64Cu]NODAGA-MAL-exendin-4 were studied and compared to [64Cu]NODAGA-exendin-4. Labeling of pancreatic islets was assessed using autoradiography.
NODAGA-MAL-exendin-4 was synthesized, with an overall yield of 9%, and radiolabeled with 64Cu with high specific radioactivity. Serum incubation studies showed high stability for [64Cu]NODAGA-MAL-exendin-4. Similar tissue distribution kinetics was observed for [64Cu]NODAGA-MAL-exendin-4 and [64Cu]NODAGA-exendin-4, with high kidney radioactivity levels.
The incorporated MAL linkage in [64Cu]NODAGA-MAL-exendin-4 was unable to reduce kidney radioactivity levels, compared to [64Cu]NODAGA-exendin-4. The applicability of metabolizable linkages in the design of kidney-saving exendin-4 analogs requires further investigation.